These developments favor therapeutic modalities, such as peptides, that can be mechanistically linked to disease pathways and monitored through pharmacodynamic readouts
biologics segment is expected to capture the majority share (over 65%) of the market by 2035
Which medication causes fewer side effects
Conclusion Tirzepatide represents a major leap forward in the treatment of type 2 diabetes and obesity
Heise T, Mari A, DeVries JH, Urva S, Li J, Pratt EJ, et al
Prior authorization criteria for Rezdiffra vary by insurance, but I know some plans require the following: (1) MASH diagnosis by liver biopsy, Fibroscan, or magnetic resonance elastography (MRE), (2) prescribed by a gastroenterologist or hepatologist